Literature DB >> 3495303

T lymphocytes lack rearrangement of the bcr gene in Philadelphia chromosome-positive chronic myelocytic leukemia.

C R Bartram, A Raghavachar, B Anger, C Stain, P Bettelheim.   

Abstract

To study the possible involvement of T lymphocytes in Philadelphia chromosome (Ph)-positive chronic myelocytic leukemia (CML) we analyzed the arrangement of the bcr gene in T cell and non-T cell samples of 12 CML patients. Although all the patients showed bcr rearrangements in non-T cell fractions, T cell populations lacked respective gene recombinations. Moreover, by Southern blot analyses using T cell receptor beta chain sequences our data indicate polyclonality of T cell samples from 11 of 12 cases; in one patient a clonal T cell population could be identified. These results suggest that T lineages of most Ph-positive CML patients are not derived from pluripotent stem cells involved in leukemogenesis and thus confirm previous investigations based on cytogenetic or glucose-6-phosphate dehydrogenase analyses. The demonstration of polyclonal T cell populations may reflect persistence of stem cells committed to differentiate only into T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495303

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.

Authors:  Salem Akel; Despina Mavroyanni; Xenophon Yataganas; Evagelos Terpos; John Meletis; Kostas Anargyrou; Niki Stavrogianni; Gerasimos-Alexander Pangalis; Dimitris Loukopoulos; Nora Viniou
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

2.  Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients.

Authors:  B Anger; F Carbonell; I Braunger; B Heinze; W Gutensohn; E Thiel; H Heimpel
Journal:  Blut       Date:  1988-09

Review 3.  Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors:  Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

4.  T-cell immunity to the joining region of p210BCR-ABL protein.

Authors:  W Chen; D J Peace; D K Rovira; S G You; M A Cheever
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia.

Authors:  N Tsukamoto; M Karasawa; T Maehara; K Okamoto; H Sakai; T Naruse; K Morita; J Tsuchiya; M Omine
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.